![](https://investorshub.advfn.com/uicon/708472.png?cb=1689926105)
Thursday, October 03, 2019 4:50:55 PM
TORONTO, ON / ACCESSWIRE / October 2, 2019 / There appears to be a control dispute for Hypertension Diagnostics, Inc. (OTC PINK:HDII) involving Mr. Liangjian Peng and another party. HDII's attorney Stephen Mills is currently dealing with the dispute. We believe this matter will be solved very soon. Mr. Peng, CEO of HDII affirms that he is sole officer and only preferred shares holder of HDII. Mr. Peng will travel to China on October 4, 2019, he will visit ShanDong GerPang Healthcare Group to discuss further cooperation between HDII and ShanDong Gerpang Healthcare Group. Thank you for all shareholders support!
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM